[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Products. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 72, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 52, "title": "Interim CEO, President, CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 332500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Gironda", "title": "Head of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.oragenics.com/?q=investors", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.1941, "open": 0.1939, "dayLow": 0.1864, "dayHigh": 0.198, "regularMarketPreviousClose": 0.1941, "regularMarketOpen": 0.1939, "regularMarketDayLow": 0.1864, "regularMarketDayHigh": 0.198, "payoutRatio": 0.0, "beta": 0.87, "forwardPE": -0.01824074, "volume": 135438, "regularMarketVolume": 135438, "averageVolume": 4797477, "averageVolume10days": 209590, "averageDailyVolume10Day": 209590, "bid": 0.1911, "ask": 0.1985, "bidSize": 10, "askSize": 18, "marketCap": 4230634, "fiftyTwoWeekLow": 0.16, "fiftyTwoWeekHigh": 3.43, "fiftyDayAverage": 0.2412, "twoHundredDayAverage": 0.48295, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3694320, "profitMargins": 0.0, "floatShares": 20952366, "sharesOutstanding": 21475300, "sharesShort": 515554, "sharesShortPriorMonth": 312636, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.024, "heldPercentInsiders": 0.13282, "heldPercentInstitutions": 0.01186, "shortRatio": 1.24, "shortPercentOfFloat": 0.024600001, "impliedSharesOutstanding": 21475300, "bookValue": -0.017, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -10567918, "trailingEps": -1.6, "forwardEps": -10.8, "lastSplitFactor": "1:60", "lastSplitDate": 1674432000, "enterpriseToEbitda": -0.351, "52WeekChange": -0.8019802, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 0.197, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 864840, "totalCashPerShare": 0.04, "ebitda": -10531424, "totalDebt": 328528, "quickRatio": 0.513, "currentRatio": 0.874, "returnOnAssets": -2.04983, "returnOnEquity": -7.1495, "grossProfits": -4114434, "freeCashflow": -6447050, "operatingCashflow": -8597382, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OGEN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1745621499, "regularMarketTime": 1745611200, "exchange": "ASE", "messageBoardId": "finmb_774436", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.49407, "regularMarketPrice": 0.197, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1077719400000, "postMarketChangePercent": 0.761427, "postMarketPrice": 0.1985, "postMarketChange": 0.00150001, "regularMarketChange": 0.00289999, "regularMarketDayRange": "0.1864 - 0.198", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 4797477, "fiftyTwoWeekLowChange": 0.037, "fiftyTwoWeekLowChangePercent": 0.23125, "fiftyTwoWeekRange": "0.16 - 3.43", "fiftyTwoWeekHighChange": -3.233, "fiftyTwoWeekHighChangePercent": -0.9425656, "fiftyTwoWeekChangePercent": -80.19802, "dividendDate": 1516579200, "earningsTimestamp": 1741982400, "earningsTimestampStart": 1747155600, "earningsTimestampEnd": 1747674000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.6, "epsForward": -10.8, "fiftyDayAverageChange": -0.044200003, "fiftyDayAverageChangePercent": -0.18325043, "twoHundredDayAverageChange": -0.28595, "twoHundredDayAverageChangePercent": -0.5920903, "priceToBook": -11.588235, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "displayName": "Oragenics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]